Nano-X Imaging ($NNOX) Korean Manufacturing and Demand Alignment Case

Investors can submit applications for the lead plaintiff role.

D. New Jersey

Court

1:26-cv-07062

Case number

03/31/2025

Class period Start

04/17/2026

Class period End

08/11/2026

Lead Plaintiff motion deadline

$NNOX investors filed a claim against Nano-X Imaging for overstating operational efficiency and product demand while concealing manufacturing costs and poor demand alignment.
After Nano-X Imaging revealed a $17.5 million impairment tied to restructuring its Korean chip manufacturing facility, $NNOX fell 24.4% on April 20, 2026.
$NNOX investors can join this case to be notified about potential recovery.
Case Details:

Between March 31, 2025 and April 17, 2026, Nano-X Imaging reported steady operational progress, scaling commercialization, and improving manufacturing efficiency. 

The company highlighted growing demand for Nanox.ARC, a strong sales pipeline, increased deployments, and ongoing efforts to build more efficient production operations.

However, investors pointed to a mismatch between manufacturing operations and actual demand. They cited that the company’s Korean chip manufacturing setup was not aligned with current and expected demand, while operating costs and cash burn were increasing. 

They also noted that parts of the manufacturing model were not sustainable, resulting in restructuring needs and impairment charges.

Then, on April 20, 2026, the company revealed a fourth-quarter net loss of $33.4 million, including a $17.5 million impairment tied to restructuring operations at its Korean facility. 

Following the update, $NNOX fell 24.4%, closing at $2.155. Later that day, the company announced a shift toward outsourced production and disclosed that its CFO would step down effective July 31, 2026.

Based on these events, $NNOX investors filed a claim against Nano-X Imaging, stating that the company:
Overstated operating efficiency.
Misrepresented demand and manufacturing progress while costs and cash burn were increasing.
Investors argue Nano-X Imaging misled the market about manufacturing efficiency, demand alignment, and cost controls, causing losses when the truth emerged.

Case Type

US Securities Class Action

Case Status

Lead Plaintiff Submission

Alleged Offence

Misleading Statements,

Financial Misrepresentation,

Fraud,

Failure to Disclose,

Omissions

Suspected Party

Directors,

Management

Security Type

Stocks

Trade Direction

Long

Shock Event Date

04/20/2026

Filing date

06/12/2026

Lead Plaintiff Deadline

08/11/2026